Robert L. Nussbaum, Chief Medical Officer at Invitae Corp (NVTA), sold 53,514 shares at $16.70 ($917K) on 2020-05-20, disclosed to the SEC on 2020-05-22.
Open-market sale of $917k NVTA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.70 | 6,864 | $115K | 12.5% |
| 2 | $16.70 | 6,864 | $115K | 12.5% |
| 3 | $17.22 | 16,859 | $290K | 31.7% |
| 4 | $17.22 | 16,859 | $290K | 31.7% |
| 5 | $17.62 | 3,034 | $53K | 5.8% |
| 6 | $17.62 | 3,034 |
| $53K |
| 5.8% |
| Total | $17.13 avg | 53,514 | $917K | 100% |
| Filing → |
| NVTA | SELL | 2023-03-15 | $4K | — | Filing → |
| NVTA | SELL | 2022-08-18 | $32K | — | Filing → |
| NVTA | SELL | 2022-05-19 | $23K | — | Filing → |